Status:
COMPLETED
Study In Adults And Adolescents With Seasonal Allergic Rhinitis.
Lead Sponsor:
GlaxoSmithKline
Conditions:
Rhinitis, Allergic, Seasonal
Eligibility:
All Genders
12+ years
Phase:
PHASE3
Brief Summary
Compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Informed consent.
- Must be an outpatient.
- Females must be using appropriate contraception.
- Must have diagnosis of seasonal allergic rhinitis, adequate exposure to allergen.
- Must be able to comply with study procedures.
- Must be literate.
- Exclusion criteria:
- A significant concomitant medical condition.
- Use of corticosteroids or allergy or medications or tobacco.
- Clinically significant abnormal ECG.
- Laboratory abnormality.
- Positive pregnancy test.
- Allergy to any component of the investigational product.
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
288 Patients enrolled
Trial Details
Trial ID
NCT00225823
Start Date
May 1 2005
End Date
August 1 2005
Last Update
September 15 2016
Active Locations (24)
Enter a location and click search to find clinical trials sorted by distance.
1
GSK Investigational Site
Tallinn, Estonia, 13419
2
GSK Investigational Site
Tartu, Estonia, 51014
3
GSK Investigational Site
Liepāja, Latvia, LV3401
4
GSK Investigational Site
Riga, Latvia, LV 1001